» Articles » PMID: 22096324

Feverfew (Tanacetum Parthenium L.): A Systematic Review

Overview
Journal Pharmacogn Rev
Date 2011 Nov 19
PMID 22096324
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Feverfew (Tanacetum parthenium L.) (Asteraceae) is a medicinal plant traditionally used for the treatment of fevers, migraine headaches, rheumatoid arthritis, stomach aches, toothaches, insect bites, infertility, and problems with menstruation and labor during childbirth. The feverfew herb has a long history of use in traditional and folk medicine, especially among Greek and early European herbalists. Feverfew has also been used for psoriasis, allergies, asthma, tinnitus, dizziness, nausea, and vomiting. The plant contains a large number of natural products, but the active principles probably include one or more of the sesquiterpene lactones known to be present, including parthenolide. Other potentially active constituents include flavonoid glycosides and pinenes. It has multiple pharmacologic properties, such as anticancer, anti-inflammatory, cardiotonic, antispasmodic, an emmenagogue, and as an enema for worms. In this review, we have explored the various dimensions of the feverfew plant and compiled its vast pharmacologic applications to comprehend and synthesize the subject of its potential image of multipurpose medicinal agent. The plant is widely cultivated to large regions of the world and its importance as a medicinal plant is growing substantially with increasing and stronger reports in support of its multifarious therapeutic uses.

Citing Articles

Bridging Gaps in Migraine Management: A Comprehensive Review of Conventional Treatments, Natural Supplements, Complementary Therapies, and Lifestyle Modifications.

Abo-Elghiet F, Elosaily H, Hussein D, El-Shiekh R, Aaqoulah A, Yousef E Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40005953 PMC: 11858087. DOI: 10.3390/ph18020139.


Allergic Potential of Medicinal Plants From the Asteraceae Family.

Kljucevsek T, Kreft S Health Sci Rep. 2025; 8(2):e70398.

PMID: 39995792 PMC: 11847717. DOI: 10.1002/hsr2.70398.


Chemical Composition of Extracts from Various Parts of Feverfew ( L.) and Their Antioxidant, Protective, and Antimicrobial Activities.

Michalak M, Stryjecka M, Zarnowiec P, Zagorska-Dziok M, Kieltyka-Dadasiewicz A Int J Mol Sci. 2024; 25(22).

PMID: 39596244 PMC: 11594288. DOI: 10.3390/ijms252212179.


Exploring the potential of Fargesin from for chronic migraine: and pharmacokinetic study.

Rushendran R, Chitra V Future Sci OA. 2024; 10(1):2428119.

PMID: 39560307 PMC: 11581172. DOI: 10.1080/20565623.2024.2428119.


Exploring the Phytochemistry, Signaling Pathways, and Mechanisms of Action of (L.) Sch.Bip.: A Comprehensive Literature Review.

Kashkooe A, Jalali A, Zarshenas M, Hamedi A Biomedicines. 2024; 12(10).

PMID: 39457613 PMC: 11505096. DOI: 10.3390/biomedicines12102297.


References
1.
Pittler M, Ernst E . Feverfew for preventing migraine. Cochrane Database Syst Rev. 2004; (1):CD002286. DOI: 10.1002/14651858.CD002286.pub2. View

2.
Waller P, Ramsay L . Efficacy of feverfew as prophylactic treatment of migraine. Br Med J (Clin Res Ed). 1985; 291(6502):1128. PMC: 1417037. DOI: 10.1136/bmj.291.6502.1128. View

3.
Groenewegen W, Knight D, Heptinstall S . Compounds extracted from feverfew that have anti-secretory activity contain an alpha-methylene butyrolactone unit. J Pharm Pharmacol. 1986; 38(9):709-12. DOI: 10.1111/j.2042-7158.1986.tb03118.x. View

4.
Miller L . Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med. 1998; 158(20):2200-11. DOI: 10.1001/archinte.158.20.2200. View

5.
Tiuman T, Ueda-Nakamura T, Garcia Cortez D, Prado Dias Filho B, Morgado-Diaz J, De Souza W . Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium. Antimicrob Agents Chemother. 2004; 49(1):176-82. PMC: 538891. DOI: 10.1128/AAC.49.11.176-182.2005. View